Publication | Open Access
Efficacy and safety of a quadrivalent influenza vaccine in children aged 6–35 months: A global, multiseasonal, controlled, randomized Phase III study
24
Citations
21
References
2022
Year
Primary vaccination with QIV was well tolerated and effective in protecting children aged 6-35 months against influenza.
| Year | Citations | |
|---|---|---|
Page 1
Page 1